BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 8879197)

  • 21. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
    Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
    J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
    Racioppi L; Ronchese F; Matis LA; Germain RN
    J Exp Med; 1993 Apr; 177(4):1047-60. PubMed ID: 8384651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptidic termini play a significant role in TCR recognition.
    Wang B; Sharma A; Maile R; Saad M; Collins EJ; Frelinger JA
    J Immunol; 2002 Sep; 169(6):3137-45. PubMed ID: 12218131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.
    Almagro JC; Vargas-Madrazo E; Lara-Ochoa F; Horjales E
    Protein Sci; 1995 Sep; 4(9):1708-17. PubMed ID: 8528069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous altered peptide ligands can affect peripheral T cell responses.
    Vidal K; Hsu BL; Williams CB; Allen PM
    J Exp Med; 1996 Apr; 183(4):1311-21. PubMed ID: 8666889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
    Schountz T; Kasselman JP; Ford SR; Murray JS
    Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bound peptide-dependent thermal stability of major histocompatibility complex class II molecule I-Ek.
    Saito K; Oda M; Sarai A; Azuma T; Kozono H
    Biochemistry; 2004 Aug; 43(31):10186-91. PubMed ID: 15287746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conserved T-cell receptor class II major histocompatibility complex contact detected in a T-lymphocyte population.
    Feng M; Chou D; Liaw Y; Lai M
    Immunology; 1998 Oct; 95(2):185-92. PubMed ID: 9824474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
    de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex.
    Williams CB; Engle DL; Kersh GJ; Michael White J; Allen PM
    J Exp Med; 1999 May; 189(10):1531-44. PubMed ID: 10330432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On defining the rules for interactions between the T cell receptor and its ligand: a critical role for a specific amino acid residue of the T cell receptor beta chain.
    Wang F; Ono T; Kalergis AM; Zhang W; DiLorenzo TP; Lim K; Nathenson SG
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5217-22. PubMed ID: 9560256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.
    Spear TT; Wang Y; Smith TW; Simms PE; Garrett-Mayer E; Hellman LM; Baker BM; Nishimura MI
    Mol Ther; 2018 Apr; 26(4):996-1007. PubMed ID: 29503203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation.
    Boots AM; Hubers H; Kouwijzer M; den Hoed-van Zandbrink L; Westrek-Esselink BM; van Doorn C; Stenger R; Bos ES; van Lierop MJ; Verheijden GF; Timmers CM; van Staveren CJ
    Arthritis Res Ther; 2007; 9(4):R71. PubMed ID: 17645792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring.
    Lanzarotti E; Marcatili P; Nielsen M
    Mol Immunol; 2018 Feb; 94():91-97. PubMed ID: 29288899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of peptide residues interacting with MHC molecule or T cell receptor. Can a peptide bind in more than one way to the same MHC molecule?
    Kurata A; Berzofsky JA
    J Immunol; 1990 Jun; 144(12):4526-35. PubMed ID: 2141038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.
    Cole DK; Bulek AM; Dolton G; Schauenberg AJ; Szomolay B; Rittase W; Trimby A; Jothikumar P; Fuller A; Skowera A; Rossjohn J; Zhu C; Miles JJ; Peakman M; Wooldridge L; Rizkallah PJ; Sewell AK
    J Clin Invest; 2016 Jun; 126(6):2191-204. PubMed ID: 27183389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.
    Vignali DA; Strominger JL
    J Exp Med; 1994 Jun; 179(6):1945-56. PubMed ID: 7515103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands.
    Zhao Y; Gran B; Pinilla C; Markovic-Plese S; Hemmer B; Tzou A; Whitney LW; Biddison WE; Martin R; Simon R
    J Immunol; 2001 Aug; 167(4):2130-41. PubMed ID: 11489997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.
    Itoh Y; Hemmer B; Martin R; Germain RN
    J Immunol; 1999 Feb; 162(4):2073-80. PubMed ID: 9973480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.